Drug news
Mundipharma to market Lodotra for RA in Middle East and Africa.
Horizon Pharma, Inc. announced that its Swiss subsidiary has signed an exclusive agreement with Mundipharma for the commercialization and distribution of Lodotra (delayed release prednisone) in the Middle East and African Region.